Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Can this be confirmed? Ignited
2
Aug 05, 2012 10:56AM
1
Aug 06, 2012 10:28AM
5
Aug 06, 2012 10:29AM

Q: What is the future direction of Patriot? Are additional M&A transactions planned? Is returning cash to the shareholders an option?

A: Patriot is not currently pursuing any acquisition opportunities. It has, and continues to, divest of interests in activities that have required continued uses of cash. While we believe Patriot currently has a relatively strong cash position, we continue to take measures to preserve resources so that we are as prepared as possible to support our interests in the MMP Portfolio and meet all challenges, both known and unforeseen. At this time a very important event in determining Patriot’s future will be the outcome in the current Northern California infringement litigation. A significant step in that process was the January 27, 2012 Markman hearing where claims construction arguments were presented to the court.

Patriot is supportive of a strategy to return cash to its shareholders however, no action in this regard is expected to be undertaken until significant uncertainties surrounding the business, litigation, and the licensing program are resolved. We, like our shareholders, anxiously await the court’s ruling from the Markman hearing.

http://patriotscientific.com/ptsc-faqs.pdf (updated 5-10-12)

11
Aug 06, 2012 11:05AM
Share
New Message
Please login to post a reply